Silence Therapeutics (NASDAQ:SLN) Upgraded at Wall Street Zen
Silence Therapeutics (NASDAQ:SLN – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday. SLN has been the subject of several other research reports. HC Wainwright reaffirmed a “buy” rating and issued a $75.00 price objective on shares […]
Silence Therapeutics (NASDAQ:SLN – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday. SLN has been the subject of several other research reports. HC Wainwright reaffirmed a “buy” rating and issued a $75.00 price objective on shares […]
